BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4064546)

  • 1. Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer.
    Quilty PM; Duncan W; Kerr GR
    Clin Radiol; 1985 Nov; 36(6):615-8. PubMed ID: 4064546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder.
    Moonen L; van der Voet H; Horenblas S; Bartelink H
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):537-42. PubMed ID: 9112450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irradiation therapy with multiple small fractions per day in urinary bladder cancer.
    Edsmyr F; Andersson L; Esposti PL; Littbrand B; Nilsson B
    Radiother Oncol; 1985 Nov; 4(3):197-203. PubMed ID: 3909239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer.
    Søndergaard J; Holmberg M; Jakobsen AR; Agerbæk M; Muren LP; Høyer M
    Acta Oncol; 2014 Oct; 53(10):1321-8. PubMed ID: 24980045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Online adaptive radiotherapy for muscle-invasive bladder cancer: results of a pilot study.
    Foroudi F; Wong J; Kron T; Rolfo A; Haworth A; Roxby P; Thomas J; Herschtal A; Pham D; Williams S; Tai KH; Duchesne G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):765-71. PubMed ID: 20932678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution.
    Tonoli S; Bertoni F; De Stefani A; Vitali E; De Tomasi D; Caraffini B; Scheda A; Bertocchi M; Somensari A; Buglione M; Magrini SM
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):52-9. PubMed ID: 16477920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer.
    Mangar SA; Foo K; Norman A; Khoo V; Shahidi M; Dearnaley DP; Horwich A; Huddart RA
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):466-73. PubMed ID: 16909970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External beam radiation treatment of urinary bladder carcinoma. An analysis of results in 203 patients.
    Salminen E
    Acta Oncol; 1990; 29(7):909-14. PubMed ID: 2261207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control.
    Moonen L; vd Voet H; de Nijs R; Horenblas S; Hart AA; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):525-30. PubMed ID: 9806510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group.
    Cox JD; Guse C; Asbell S; Rubin P; Sause WT
    Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1331-6. PubMed ID: 3058657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
    Chen WC; Liaw CC; Chuang CK; Chen MF; Chen CS; Lin PY; Chang PL; Chu SH; Wu CT; Hong JH
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):726-33. PubMed ID: 12788178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical radiotherapy with salvage surgery for invasive bladder cancer: results following a reduction in radiation dose.
    Whillis D; Howard GC; Kerr GR; Fowler J; Hargreave TB; Chisholm GD
    J R Coll Surg Edinb; 1992 Feb; 37(1):42-5. PubMed ID: 1573607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy.
    Duncan W; Quilty PM
    Radiother Oncol; 1986 Dec; 7(4):299-310. PubMed ID: 3101140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.
    Murthy V; Masodkar R; Kalyani N; Mahantshetty U; Bakshi G; Prakash G; Joshi A; Prabhash K; Ghonge S; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):60-66. PubMed ID: 26547385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model.
    Jereczek-Fossa B; Jassem J; Nowak R; Badzio A
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):329-38. PubMed ID: 9607348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated radiotherapy for patients with carcinoma of the bladder.
    Jose CC; Price A; Norman A; Jay G; Huddart R; Dearnaley DP; Horwich A
    Clin Oncol (R Coll Radiol); 1999; 11(5):330-3. PubMed ID: 10591821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
    Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder.
    Poortmans PM; Richaud P; Collette L; Ho Goey S; Pierart M; Van Der Hulst M; Bolla M;
    Acta Oncol; 2008; 47(5):937-40. PubMed ID: 18568488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole Versus Partial Bladder Radiation: Use of an Image-guided Hypofractionated IMRT Bladder-preservation Protocol.
    Kang JJ; Steinberg ML; Kupelian P; Alexander S; King CR
    Am J Clin Oncol; 2018 Feb; 41(2):107-114. PubMed ID: 26535994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.